Factors associated with Group A Streptococcus emm type diversification in a large urban setting in Brazil: A cross-sectional study

BMC Infectious Diseases

Volumn 10, Issue , 2010, Pages

  Tartof, Sara Y ^a   Reis, Joice N ^b,d   Andrade, Aurelio N ^c   Ramos, Regina T ^b   Reis, Mitermayer G ^d   Riley, Lee W ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b FEDERAL UNIVERSITY OF BAHIA   (Brazil)

^c HOSPITAL SÃO RAFAEL   (Brazil)

^d INSTITUTO OSWALDO CRUZ   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

ADOLESCENT; ARTICLE; BACTERIAL GENE; BACTERIUM CULTURE; BACTERIUM ISOLATE; BRAZIL; CHILD; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; DISEASE ASSOCIATION; DISEASE SEVERITY; EMM GENE; FEMALE; GENE ACTIVITY; GENE IDENTIFICATION; GENE SEQUENCE; GENETIC VARIABILITY; GROUP A STREPTOCOCCAL INFECTION; HUMAN; INFECTION PREVENTION; INFECTION RISK; MAJOR CLINICAL STUDY; MOUSE; NONHUMAN; PRESCHOOL CHILD; SORE THROAT; STREPTOCOCCUS GROUP A; THROAT CULTURE; URBAN AREA; BACTERIUM IDENTIFICATION; CLASSIFICATION; CLINICAL TRIAL; COMPARATIVE STUDY; GENETICS; GENOTYPE; ISOLATION AND PURIFICATION; MALE; MICROBIOLOGY; MULTICENTER STUDY; PHARYNGITIS; POVERTY; STREPTOCOCCUS INFECTION; STREPTOCOCCUS PYOGENES; URBAN POPULATION;

ADOLESCENT; BACTERIAL TYPING TECHNIQUES; BRAZIL; CHILD; CHILD, PRESCHOOL; CROSS-SECTIONAL STUDIES; FEMALE; GENETIC VARIATION; GENOTYPE; HUMANS; MALE; PHARYNGITIS; POVERTY AREAS; STREPTOCOCCAL INFECTIONS; STREPTOCOCCUS PYOGENES; URBAN POPULATION;

EID: 78149337592     PISSN: None     EISSN: 14712334     Source Type: Journal    
DOI: 10.1186/1471-2334-10-327     Document Type: Article

References (26)

1. Cunningham MW. Pathogenesis of group A streptococcal infections. Clin Microbiol Rev 2000, 13(3):470-511. 10.1128/CMR.13.3.470-511.2000, 88944, 10885988.
2. Bisno AL. Streptococcus pyogenes. Principles and Practice of Infectious Diseases 1990, 1519-1528. New York: Churchill Livingstone, Gerald L Mandell GD, John E Bennett, Third.
3. Carapetis JR, Steer AC, Mulholland EK, Weber M. The global burden of group A streptococcal diseases. Lancet Infect Dis 2005, 5(11):685-694. 10.1016/S1473-3099(05)70267-X, 16253886.
4. Beall B, Facklam R, Thompson T. Sequencing emm-specific PCR products for routine and accurate typing of group A streptococci. J Clin Microbiol 1996, 34(4):953-958. 228924, 8815115.
5. Stollerman GH. The relative rheumatogenicity of strains of group A streptococci. Mod Concepts Cardiovasc Dis 1975, 44(7):35-40.
6. Veasy LG, Tani LY, Daly JA, Korgenski K, Miner L, Bale J, Kaplan EL, Musser JM, Hill HR. Temporal association of the appearance of mucoid strains of Streptococcus pyogenes with a continuing high incidence of rheumatic fever in Utah. Pediatrics 2004, 113(3 Pt 1):e168-172. 10.1542/peds.113.3.e168, 14993572.
7. Miner LJ, Petheram SJ, Daly JA, Korgenski EK, Selin KS, Firth SD, Veasy LG, Hill HR, Bale JF. Molecular characterization of Streptococcus pyogenes isolates collected during periods of increased acute rheumatic fever activity in Utah. Pediatr Infect Dis J 2004, 23(1):56-61. 10.1097/01.inf.0000105180.76624.33, 14743048.
8. Kaplan EL, Johnson DR, Cleary PP. Group A streptococcal serotypes isolated from patients and sibling contacts during the resurgence of rheumatic fever in the United States in the mid-1980s. J Infect Dis 1989, 159(1):101-103.
9. O'Loughlin RE, Roberson A, Cieslak PR, Lynfield R, Gershman K, Craig A, Albanese BA, Farley MM, Barrett NL, Spina NL, et al. The epidemiology of invasive group A streptococcal infection and potential vaccine implications: United States, 2000-2004. Clin Infect Dis 2007, 45(7):853-862. 10.1086/521264, 17806049.
10. Dale JB. Multivalent group A streptococcal vaccine designed to optimize the immunogenicity of six tandem M protein fragments. Vaccine 1999, 17(2):193-200. 10.1016/S0264-410X(98)00150-9, 9987154.
11. Batzloff MRPM, Olive C, Good MF. Advances in potential M-protein peptide-based vaccines for preventing rheumatic fever and rheumatic heart disease. Immunol Res 2006, 35(3):233-248. 10.1385/IR:35:3:233, 17172649.
12. McNeil SA, Halperin SA, Langley JM, Smith B, Warren A, Sharratt GP, Baxendale DM, Reddish MA, Hu MC, Stroop SD, et al. Safety and immunogenicity of 26-valent group a streptococcus vaccine in healthy adult volunteers. Clin Infect Dis 2005, 41(8):1114-1122. 10.1086/444458, 16163629.
13. Abdissa A, Asrat D, Kronvall G, Shittu B, Achiko D, Zeidan M, Yamuah LK, Aseffa A. High diversity of group A streptococcal emm types among healthy schoolchildren in Ethiopia. Clin Infect Dis 2006, 42(10):1362-1367. 10.1086/503422, 16619146.
14. Dey N, McMillan DJ, Yarwood PJ, Joshi RM, Kumar R, Good MF, Sriprakash KS, Vohra H. High diversity of group A Streptococcal emm types in an Indian community: the need to tailor multivalent vaccines. Clin Infect Dis 2005, 40(1):46-51. 10.1086/426443, 15614691.
15. Kim SJ, Kim EC, Cha SH, Kaplan EL. Comparison of M-serotypes of Streptococcus pyogenes isolated from healthy elementary school children in two rural areas. J Korean Med Sci 1996, 11(2):133-136.
16. Tanaka D, Gyobu Y, Kodama H, Isobe J, Hosorogi S, Hiramoto Y, Karasawa T, Nakamura S. emm Typing of group A streptococcus clinical isolates: identification of dominant types for throat and skin isolates. Microbiol Immunol 2002, 46(7):419-423.
17. Johnson DR, Stevens DL, Kaplan EL. Epidemiologic analysis of group A streptococcal serotypes associated with severe systemic infections, rheumatic fever, or uncomplicated pharyngitis. J Infect Dis 1992, 166(2):374-382.
18. Smeesters PR, Vergison A, Campos D, de Aguiar E, Deyi VY, Van Melderen L. Differences between Belgian and Brazilian Group A Streptococcus Epidemiologic Landscape. PLoS ONE 2006, 1:e10. 10.1371/journal.pone.0000010, 1762354, 17183632.
19. Steer AC, Law I, Matatolu L, Beall BW, Carapetis JR. Global emm type distribution of group A streptococci: systematic review and implications for vaccine development. Lancet Infect Dis 2009, 9(10):611-616. 10.1016/S1473-3099(09)70178-1, 19778763.
20. Programme UNHS The challenge of slums: global report on human settlements 2003. 2003, Nairobi: UN HABITAT, Programme UNHS.
21. Bisno AL, Gerber MA, Gwaltney JM, Kaplan EL, Schwartz RH. Practice guidelines for the diagnosis and management of group A streptococcal pharyngitis. Infectious Diseases Society of America. Clin Infect Dis 2002, 35(2):113-125. 10.1086/340949, 12087516.
22. Simpson E. Measurement of diversity. Nature 1949, 163:688.
23. Grundmann H, Hori S, Tanner G. Determining confidence intervals when measuring genetic diversity and the discriminatory abilities of typing methods for microorganisms. J Clin Microbiol 2001, 39(11):4190-4192. 10.1128/JCM.39.11.4190-4192.2001, 88515, 11682558.
24. Hu MC, Walls MA, Stroop SD, Reddish MA, Beall B, Dale JB. Immunogenicity of a 26-valent group A streptococcal vaccine. Infect Immun 2002, 70(4):2171-2177. 10.1128/IAI.70.4.2171-2177.2002, 127884, 11895984.
25. Kyobutungi C, Ziraba AK, Ezeh A, Ye Y. The burden of disease profile of residents of Nairobi's slums: Results from a Demographic Surveillance System. Popul Health Metr 2008, 6:1. 10.1186/1478-7954-6-1, 2292687, 18331630.
26. Madise NJ, Banda EM, Benaya KW. Infant mortality in Zambia: socioeconomic and demographic correlates. Soc Biol 2003, 50(1-2):148-166.